Investing
Futures were lower on Friday, after a rollercoaster week and month that began with some heavy selling. It looks ready to end the way it started, with more sales. Finally, all major indexes have found a way to close higher Thursday, with a massive across-the-board rally despite the gloomy negative report of gross domestic product in the first quarter and interest rates. is rising again.
Some very solid revenue numbers and technology guidance helped along with very oversold conditions, cited as the main cause of the big bounce, but poor revenue reports from Amazon and Apple added to the pressure on Friday.
The aforementioned interest rate shifts were seen across the Treasury curve, with the 30-year government bond again closing at a 3% hold. The good news for Wall Street is that the Treasury yield curve is a bit higher and avoids the inversion status we saw earlier this month.
24/7 Wall St. reviews. dozens of analyst research reports every day of the week with the goal of finding new ideas for investors and traders. Some of this analyst’s daily calls cover stocks to buy. Other calls cover stocks to be sold or avoided. Note that no one analyst call should be used as the basis for buying or selling a stock. The consensus analyst’s target data is from Refinitiv.
These are the top upgrades, downgrades, and startups the analyst saw on Friday, April 29, 2022.
Align Technology Inc. (NASDAQ: ALGN): Baird reiterated the Outperform rating on the stock but reduced the $ 625 target price to $ 510. The consensus target is (for now) at $ 606.92. The shares were last seen Thursday at $ 304.66, down nearly 16% after the company posted disappointing earnings.
Amedisys Inc. (NASDAQ: AMED): Oppenheimer reiterated an Outperform rating and has a $ 200 price target. The target consensus is $ 186.93. The stock was last seen on Thursday trading at $ 131.89.
Amgen Inc. (NASDAQ: AMGN): Goldman Sachs maintained a Buy rating on the biotech giant after earnings, and it has a $ 291 target price. The target consensus is $ 248.64. The stock closed Thursday at $ 238.13, down more than 4% on the day.
Amphenol Corp. (NYSE: APH): Baird has maintained an Outperform rating and has an $ 85 target price. The target consensus is $ 86.69. The last trade for Thursday was reported at $ 73.55, up nearly 5% on the day.